Polygenic Risk Score (PRS) estimates your lifetime risk for major conditions like heart disease, stroke, diabetes, Alzheimers, osteoporosis, and several cancers (including breast, prostate, and ovarian)
Reported Effects Reduced dependence on intravenous nutrition the pivotal result: In the 24-week STEPS trial (n=86), 63% of teduglutide patients vs 30% on placebo achieved at least a 20% reduction in weekly parenteral support volume (p=0.002), a mean reduction of 4.4 L/week vs 2.3 L/week [2]
After five-time panning procedure, the fraction of unbound E
Elevate your defense mechanisms and stay resilient year-round
Millions of people worldwide deal with knee discomfort that affects their daily activities, from climbing stairs to enjoying recreational sports
Tirzepatide cardiovascular outcome data from the SURPASS-CVOT trial extends these findings to the dual agonist